Geun-Hong Min

Title: Geun-Hong Min: Innovator in Antifungal Remedies

Introduction

Geun-Hong Min is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of medical formulations, particularly in antifungal remedies. His innovative work has led to the development of a unique formulation that addresses various dermatological conditions.

Latest Patents

Geun-Hong Min holds a patent for an antifungal remedy formulation for external application. This formulation includes fluconazole, a well-known antifungal agent, and is designed for effective treatment of dermatomycosis-related infectious diseases. The composition comprises a base material, 0.1-5.0 percent by weight of fluconazole, and 1.0-40.0 percent by weight of compounds such as fatty acids and alcohols. The formulation is advantageous due to its favorable absorption through the skin, reduced skin irritation, and excellent stability. It is particularly effective for conditions like tinea pedis, tinea corporis, tinea cruris, tinea versicolor, and candidiasis.

Career Highlights

Geun-Hong Min is associated with Boryung Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing treatment options for fungal infections, showcasing his commitment to improving patient care through effective medical solutions.

Collaborations

Geun-Hong Min has collaborated with notable colleagues such as Sang-Lin Kim and Hyun-Kwang Tan. Their combined expertise has contributed to the successful development of innovative formulations in the pharmaceutical industry.

Conclusion

Geun-Hong Min's contributions to antifungal remedies highlight his role as a key innovator in the pharmaceutical field. His patented formulation represents a significant advancement in the treatment of skin infections, demonstrating the impact of his work on medical science.